Dr. Jeon is an assistant research scientist in the Department of Epidemiology at the University of Michigan. She received her B.S. and M.S. in Mathematics from the Ewha Womans University, and M.S. in Statistics and Ph.D. in Applied Mathematics from the University of Washington. After receiving her Ph.D., Dr. Jeon spent two years as a postdoctoral fellow and five years as a staff scientist at the Fred Hutchinson Cancer Research Center.
Dr. Jeon is a core member of large multidisciplinary national consortia: the Lung Cancer group of the NCI consortium ‘Cancer Intervention and Surveillance Modeling Network (CISNET)’, Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), and Colorectal Transdisciplinary (CORECT) Study in the Genetic Associations and Mechanisms in Oncology (GAME-ON). And she is also currently affiliated to the Biomedical Prevention Research Program at the University of Michigan Comprehensive Cancer Center (UMCCC), the Michigan Institute for Computational Discovery and Engineering (MICDE), and the Fred Hutchinson Cancer Research Center (FHCRC).
M.S., Mathematics, Ewha Womans University, South Korea, 1998
M.S., Statistics, University of Washington, 2005
Ph.D., Applied Mathematics, University of Washington, 2007
Research Interests & Projects
Dr. Jeon’s research interests are interdisciplinary and utilize methods from the fields
of applied mathematics, biostatistics, and epidemiology. Specifically, her work focuses
on developing biologically based mathematical models and statistical methods to evaluate
the impact of risk factors on various cancers, and the efficacy of screening to reduce
cancer incidence and/or mortality. The goal of these modeling efforts is to address
important practical public health questions and to assist public health policy makers
in their decision process. Particularly her majority efforts lie in to better understand
the underlying mechanism of the natural history of cancer and developing innovative
methodologies and computational tools to predict the risk of cancer.
Dr. Jeon’s current projects include developing mathematical models and simulation tools to investigate the synergistic impacts of tobacco control policies and CT screening on lung cancer risk in the US and in some middle-income countries. She is also developing risk prediction models for colorectal cancer that incorporate genetic variants identified form GWAS study along with environmental risk factors and modifiable lifestyle factors in population based and prospective studies. Her research interests also lie in the model and design of individually tailored health strategies given the person’s risk profile in terms of genetic variants as well as lifestyle and environmental risk factors; collectively, these provide a more accurate risk stratification of individuals.
- Hsu L, Jeon J (joint first author), Brenner H, Gruber SB, Schoen RE, Berndt SI, Chan AT, Chang-Claude J, Du M, Gong J, Harrison TA, Hayes RB, Hoffmeister M, Hutter CM, Lin Y, Nishihara R, Ogino S, Prentice RL, Schumacher FR, Seminara D, Slattery ML, Thomas DC, Thornquist M, Newcomb PA, Potter JD, Zheng Y, White E, and Peters U; Colorectal Transdisciplinary (CORECT) Study and Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO). A Model to Determine Colorectal Cancer Risk Using Common Ge- netic Susceptibility Loci. Gastroenterology. 148(7):1330-1339.e14 (2015)
- Jeon J, Meza R, Hazelton WD, Renehan AG, and Luebeck EG. Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven anal- ysis. Cancer Causes Control. 26(6):859-70 (2015).
- Holford TR, Meza R, Warner KE, Meernik C, Jeon J, Moolgavkar SH, and Levy DT. Tobacco Control and the Reduction in Smoking-related Premature Deaths in the United States, 1964- 2012. JAMA. 311(2):164-71 (2014).
- de Koning HJ, Meza R, Plevritis SK, Ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, de Gonzalez AB, Berg CD, Black WC, Tammemagi MC, Hazelton WD, Feuer EJ, and McMahon PM. Benefits and Harms of Com- puted Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force. Ann Intern Med. 160(5):311-20 (2014).
- Holford TR, Levy DT, McKay LA, Clarke L, Racine B, Meza R, Land S, Jeon J, and Feuer EJ. Patterns of Birth Cohort-Specific Smoking Histories, 1965-2009. Am J Prev Med. 46(2), e31-7 (2014).
- Moolgavkar SH, Holford TR, Levy DT, Kong C, Foy M, Clarke L, Jeon J, Hazelton WD, Meza R, Schultz F, McCarthy WJ, Boer R, Gorlova O, Gazelle GS, Kimmel M, McMahon PM, Koning HJ, Feuer EJ. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst. 104(7):541-8 (2012).
- Jeon J, Meza R, Krapcho M, Clarke L, Byrne J, and Levy DT. Actual and counterfactual smoking prevalence rates in the US population via microsimulation. Risk Anal. Suppl 1:S51- 68 (2012).
- Meza R, Jeon J, Renehan AG, and Luebeck EG. Colorectal cancer incidence trends in the United States and United kingdom: evidence of right- to left-sided biological gradients with implications for screening. Cancer Res. 70(13): 5419-29 (2010).
- Meza R, Jeon J, Moolgavkar SH, and Luebeck EG. Age-specific Incidence of Cancer: phases, transitions and biological implications, Proc Natl Acad Sci U S A. 105(42): 16284-9 (2008).
- Jeon J, Meza R, Moolgavkar SH, and Luebeck EG. Evaluation of Screening Strategies for Pre- malignant Lesions using a Biomathematical Approach, Math Biosci. 213(1): 56-70 (2008).